HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Top Medical News

Infectious Disease Update: This Week's Top 5 Stories

December 2nd 2022

With major updates in HIV, C difficile, hepatitis, yeast infections, and skin and soft tissue infections, this week's Infectious Disease Update has something for everyone.

Experimental HIV Vaccine Elicits Broadly Neutralizing Antibodies

December 2nd 2022

A germline-targeting HIV vaccine candidate elicited broadly neutralizing antibodies in 97% of recipients.

Considering Criteria for Admission for Skin and Soft Tissue Infections

December 2nd 2022

In episode 1 of this short video series, a clinician discusses what types of patients are best suited for inpatient or outpatient care for these infections.

Utilizing a Novel Modality to Treat Pulmonary Fungal Infections in Lung Transplant Patients

December 2nd 2022

Two patients at a hospital in Australia were administered Thin Film Freezing Voriconazole Inhalation Powder (TFF VORI), which showed treatment efficacy for both patients.

Lyme Disease Vaccine Shows Antibodies 6 Months after Completion

December 1st 2022

The investigational shot from Pfizer and Valneva demonstrated higher antibody levels in the three-dose vaccination schedule versus the two-dose vaccination schedule.

Conference Coverage
View All >>

Opinions of Oral Versus Injectable HIV PrEP in a Racially Diverse Cohort

November 16th 2022

Concerns of injectable HIV PrEP safety and efficacy demonstrate a need for health care providers to share reliable information with at-risk populations.

Has HIV PrEP Uptake Increased Among High-Risk Persons?

November 15th 2022

Although HIV PrEP uptake is gradually increasing, usage remains low among key at-risk populations.

Indicators of Severe Outcomes in Chronic Hepatitis B Patients

November 14th 2022

What are the characteristics and demographics of the chronic hepatitis B patients who develop severe outcomes?

Best of IDWeek 2022

November 4th 2022

Experts discuss a range of the most topical infectious disease research, presented at the recent IDWeek 2022 conference.

Video Interviews
View All >>
Promising Phase 3 Data Suggest Efficacy of Ibrexafungerp for Vaginal Yeast Infection
Binge Drinking Increases the Risk of COVID-19 Infection
Protecting Infants, Young Children by Vaccinating Teens and Adults
Did the COVID-19 Pandemic Affect Young Women’s Substance Use? Part 1
Novel Inhibitor for Treating Hospitalized Patients With COVID-19
Health Equity and Vaccines: A Combination of Internal and External Forces Drove Low Rates
Bridging the Gap: Finding Treatments for Moderate COVID-19 Disease
Highlighting IDWeek Abstracts With Thomas Lodise, PharmD, PhD
Analyzing Remdesivir Resistance, 2 Years and Many Variants Later
Developing a System to Distinguish C Diff Colonization from Infection Within a Health System
Bolstering Influenza Vaccination in People With HIV During COVID-19
Investigational Antibiotic Data Confirms Benefit for Acinetobacter Baumannii Infections
Taking the Guesswork out of ICU Pneumonia Diagnosis
A Rapid Sepsis Diagnostic Test for Better Patient Outcomes
Assessing Antimicrobial Prescribing for FEP-Susceptible ESBL-E BSIs
Podcasts
View All >>
C difficile, Antimicrobials, and the Patients Most Affected
World Hepatitis Day: Where Do We Go From Here?
ACIP Preferentially Recommends Fluzone High-Dose Influenza Vaccine for Seniors
"A Social and Political Pandemic”: HIV Disparities in LGBTQ+ People
Forging an Evolutionary Regulatory Path for Antibiotic Development
“We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs
Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Vaccine Inequity With Dr. Leonard Friedland
Vaccine Race: The Pfizer Vaccine with William Schaffner, MD
COVID-19 Vaccine Race: FDA Advisory Committee Meeting with Donald Alcendor, PhD